Raphael Pharmaceutical (RAPH) Total Current Liabilities (2020 - 2025)
Raphael Pharmaceutical (RAPH) posted Total Current Liabilities of $1.5 million for Q4 2025, up 16.92% sequentially from $1.3 million in Q3 2025, and up 93.24% YoY from $769000.0 in Q4 2024.
Raphael Pharmaceutical (RAPH) Total Current Liabilities (2020 - 2025) Analysis & Trends
Raphael Pharmaceutical has reported Total Current Liabilities for 6 years, with the latest figure at $1.5 million in Q4 2025.
- Quarterly Total Current Liabilities rose 93.24% year-over-year to $1.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.5 million (up 93.24% YoY) and the FY2025 annual result came in at $1.5 million, up 93.24% from the prior year.
- Total Current Liabilities improved to $1.5 million in Q4 2025 per RAPH's latest filing, from $1.3 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $1.5 million in Q4 2025 and troughed at $77000.0 in Q1 2022.
- A 5-year average of $498166.7 and a median of $356000.0 in 2021 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2023 and 2024: Total Current Liabilities plunged 41.85% in 2023, then surged 482.58% in 2024.
- Over 5 years, Total Current Liabilities stood at $294000.0 in 2021, then fell by 22.79% to $227000.0 in 2022, then plunged by 41.85% to $132000.0 in 2023, then soared by 482.58% to $769000.0 in 2024, then soared by 93.24% to $1.5 million in 2025.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $1.5 million, $1.3 million, and $1.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 1.79 Bn |
| 10 | Raphael Pharmaceutical | 28.25 Mn | 28.25 Mn | - | 1.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.49 Mn |
| Sep 30, 2025 | 1.27 Mn |
| Jun 30, 2025 | 1.08 Mn |
| Mar 31, 2025 | 827,000.00 |
| Dec 31, 2024 | 769,000.00 |
| Sep 30, 2024 | 667,000.00 |
| Jun 30, 2024 | 418,000.00 |
| Mar 31, 2024 | 456,000.00 |
| Dec 31, 2023 | 132,000.00 |
| Sep 30, 2023 | 478,000.00 |
| Jun 30, 2023 | 180,000.00 |
| Mar 31, 2023 | 159,000.00 |
| Dec 31, 2022 | 227,000.00 |
| Sep 30, 2022 | 183,000.00 |
| Jun 30, 2022 | 78,000.00 |
| Mar 31, 2022 | 77,000.00 |
| Dec 31, 2021 | 294,000.00 |
| Sep 30, 2021 | 187,000.00 |
| Dec 31, 2020 | 366,000.00 |